uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 15, 2016

Seller of Vision Supplements Warned for Drug Claims

On April 28, 2016, the FDA issued a warning letter to Macular Health, LLC., following a review of the company's website which found statements made about MacuStrip, Visual Advantage AREDS II Formula, Visual Advantage Premier Formula, Antioxidant Only Genetic Formula, Zinc Only Genetic Formula, Low Dose Zinc Genetic Formula, Blephadex Eyelid Wipes, Blephadex Eyelid Foam, and Visual Advantage Dry Eye Formula to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at